Literature DB >> 26776575

Pharmacotherapy of feline cardiomyopathy: Chronic management of heart failure.

Sonya G Gordon1, Etienne Côté2.   

Abstract

The natural progression of cardiomyopathy in cats can lead to congestive heart failure. This review enumerates commonly and uncommonly used medications that can be used for the long-term treatment of cats that have positively responded to initial management of acute heart failure. The advantages, drawbacks, and authors' preferred approach are presented for each medication.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac; Cardiovascular; Cat

Mesh：

Substances：

Year:  2015        PMID： 26776575     DOI： 10.1016/j.jvc.2015.03.009

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN： 1760-2734            Impact factor:   1.701


  3 in total

1.  Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial.

Authors:  Jonathan N King; Mike Martin; Valérie Chetboul; Luca Ferasin; Anne T French; Günther Strehlau; Wolfgang Seewald; Sarah G W Smith; Simon T Swift; Susan L Roberts; Andrea M Harvey; Christopher J L Little; Sarah M A Caney; Kerry E Simpson; Andrew H Sparkes; Eleanor J Mardell; Eric Bomassi; Claude Muller; John P Sauvage; Armelle Diquélou; Matthias A Schneider; Laurence J Brown; David D Clarke; Jean-Francois Rousselot
Journal:  J Vet Intern Med       Date:  2019-09-27       Impact factor: 3.333

2.  Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.

Authors:  Keisuke Sugimoto; Takuma Aoki; Yoko Fujii
Journal:  J Vet Med Sci       Date:  2020-03-19       Impact factor: 1.267

3.  Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.

Authors:  Maureen S Oldach; Yu Ueda; Eric S Ontiveros; Samantha L Fousse; Lance C Visser; Joshua A Stern
Journal:  BMC Vet Res       Date:  2021-02-23       Impact factor: 2.741
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.